Sartorius Stedim Biotech S.A. (SDMHF)

214,00 0,00 (0,00%) Alla chiusura: 02:39PM EDT

Sartorius Stedim Biotech S.A.

Zone Industrielle Les Paluds
Avenue de Jouques – CS 91051 Cedex
Aubagne 13781
France
33 4 42 84 56 00
https://www.sartorius.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 10.493

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Rene Faber	CEO & DIrector	575,51k	N/D	1975
Mr. Rainer Lehmann	CFO & Member of Executive Board	N/D	N/D	1975
Ms. Petra Muller	Head of Investor Relations	N/D	N/D	N/D
Ms. Petra Kirchhoff	Head of Corporate Communications & IR	N/D	N/D	1969
Olivier Guitard	Head of Controlling BPS	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Governance aziendale

L'ISS Governance QualityScore di Sartorius Stedim Biotech S.A. al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 4; diritti degli azionisti: 9; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.